SyntekaBio, Inc. (KOSDAQ:226330)
South Korea
· Delayed Price · Currency is KRW
7,210.00
-310.00 (-4.12%)
At close: Mar 28, 2025, 3:30 PM KST
SyntekaBio Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -7,213 | -11,398 | -4,506 | -14,803 | -6,488 |
| Depreciation & Amortization | 2,254 | 1,762 | 1,473 | 1,158 | 1,058 |
| Loss (Gain) From Sale of Assets | 5.73 | - | -0.13 | - | -0.15 |
| Asset Writedown & Restructuring Costs | 1.26 | 72 | 20.25 | - | - |
| Stock-Based Compensation | 572.84 | 779.78 | 793.17 | 364.78 | 568.15 |
| Provision & Write-off of Bad Debts | - | - | - | -0.27 | -0.52 |
| Other Operating Activities | -5,977 | 778.98 | -5,813 | 6,984 | -20.39 |
| Change in Accounts Receivable | 0.06 | 0.83 | 53.97 | -32.15 | 6.19 |
| Change in Unearned Revenue | - | - | -171.11 | - | - |
| Change in Other Net Operating Assets | -152.95 | -73.97 | -360.5 | 288.52 | 208.86 |
| Operating Cash Flow | -10,509 | -8,078 | -8,511 | -6,040 | -4,668 |
| Capital Expenditures | -5,707 | -9,364 | -8,389 | -7,479 | -788.88 |
| Sale of Property, Plant & Equipment | - | - | 0.13 | - | 0.15 |
| Sale (Purchase) of Intangibles | -109.79 | -65.61 | -368.06 | -69.14 | -97.51 |
| Investment in Securities | - | - | 39,000 | -560 | -10,440 |
| Other Investing Activities | 20 | -0 | -9.96 | 4.52 | -60 |
| Investing Cash Flow | -5,797 | -9,430 | 30,233 | -8,104 | -11,386 |
| Long-Term Debt Issued | 10,000 | 10,000 | - | 25,000 | - |
| Long-Term Debt Repaid | -1,730 | -8,228 | -263.16 | -402 | -430.8 |
| Net Debt Issued (Repaid) | 8,270 | 1,772 | -263.16 | 24,598 | -430.8 |
| Issuance of Common Stock | 262 | 12 | 174.13 | 414.15 | 1,657 |
| Other Financing Activities | -0 | -0 | - | 196.51 | 261.31 |
| Financing Cash Flow | 8,532 | 1,784 | -89.03 | 25,209 | 1,488 |
| Foreign Exchange Rate Adjustments | 171.5 | 48.83 | -0.08 | -6.44 | - |
| Miscellaneous Cash Flow Adjustments | - | - | - | - | 0 |
| Net Cash Flow | -7,602 | -15,674 | 21,634 | 11,058 | -14,567 |
| Free Cash Flow | -16,216 | -17,442 | -16,899 | -13,520 | -5,457 |
| Free Cash Flow Margin | -13413.89% | -14133.89% | -6926.24% | -4269.46% | -895.05% |
| Free Cash Flow Per Share | -1063.33 | -1218.13 | -1250.52 | -1004.13 | -411.97 |
| Cash Income Tax Paid | -130.56 | 42.79 | 67.64 | -8.71 | 40.21 |
| Levered Free Cash Flow | -19,769 | -9,212 | -1,735 | -15,780 | - |
| Unlevered Free Cash Flow | -18,514 | -8,977 | -952.52 | -15,621 | - |
| Change in Net Working Capital | 6,520 | -5,790 | -13,026 | 3,916 | - |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.